Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH) For Its Upcoming Dividend?

robot
Abstract generation in progress

Zimmer Biomet Holdings (NYSE: ZBH) is set to trade ex-dividend shortly, with a payment of US$0.24 per share, resulting in a trailing yield of 1.1%. The company demonstrates strong dividend sustainability, paying out a modest 27% of earnings and 17% of free cash flow, alongside robust earnings per share growth of 18% over the past five years. This combination of growth, conservative payout ratios, and dividend increases suggests ZBH could be an attractive option for dividend-focused investors.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin